Ubs Oconnor LLC Mirum Pharmaceuticals, Inc. Transaction History
Ubs Oconnor LLC
- $1.72 Billion
- Q2 2024
A detailed history of Ubs Oconnor LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 10,000 shares of MIRM stock, worth $387,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$387,000% of portfolio
0.02%Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$251 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$193 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$169 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$140 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$125 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.42B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...